|
CANIVERM tbl. ad us.vet.
|
-
|
V/NRP/03/1589
|
Bioveta, a.s., Čehija
|
QP52AA51
|
dogs; cats; wolves; jackals; lions; hyenas
|
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Fenbendazole, Pyrantel embonate, Praziquantel
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
09-Feb-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 20042021LI (20-Apr-2021)
|
| Labelling text: |
[PDF] 201017M (24-Oct-2017)
|
| Summary of product characteristics: |
[DOCX] 20042021ZA (20-Apr-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/03/1589-01 |
0,7 g |
2 |
Blisteris, 1 tablete |
-
|
| V/NRP/03/1589-02 |
0,7 g |
6 |
Blisteris, 1 tablete |
-
|
| V/NRP/03/1589-03 |
0,7 g |
100 |
Blisteris, 1 tablete |
-
|
| V/NRP/03/1589-04 |
0,175 g |
2 |
Blisteris, 1 tablete |
-
|
| V/NRP/03/1589-05 |
0,175 g |
6 |
Blisteris, 1 tablete |
-
|
| V/NRP/03/1589-06 |
0,175 g |
100 |
Blisteris, 1 tablete |
-
|
|